Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The cardiometabolic consequences of workplace sexual harassment.

Walli-Attaei M. and Bosch J., (2024), Eur J Prev Cardiol

Health-related quality of life & healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EORP-AF General Long-Term Registry.

Walli-Attaei M. et al, (2024), Europace

Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry

Walli-Attaei M. et al, (2024), The Lancet Global Health

Economic burden of cardiovascular diseases in the European Union: a population-based cost study.

Luengo-Fernandez R. et al, (2023), Eur Heart J

New Approaches Needed to Improve Prevention of Cardiovascular Disease

Schwalm JD. et al, (2023), JAMA Network Open

Comparing estimates of household expenditures between pictorial diaries and surveys in three low- and middle-income countries.

Murphy A. et al, (2023), PLOS Glob Public Health, 3

When the technical is also normative: a critical assessment of measuring health inequalities using the concentration index-based indices

Contoyannis P. et al, (2022), Population Health Metrics, 20

The cost implications of a polypill for primary prevention in the TIPS-3 trial

Lamy A. et al, (2022), European Heart Journal - Quality of Care and Clinical Outcomes, 8, 899 - 908

Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study

Walli-Attaei M. et al, (2022), The Lancet, 400, 811 - 821

Variations in the financial impact of the COVID-19 pandemic across 5 continents: A cross-sectional, individual level analysis

Khetan AK. et al, (2022), eClinicalMedicine, 44, 101284 - 101284

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

Walli-Attaei M. et al, (2020), The Lancet, 396, 97 - 109

Inequality aversion in income, health, and income-related health

Hurley J. et al, (2020), Journal of Health Economics, 70, 102276 - 102276

The household economic burden of non-communicable diseases in 18 countries

Murphy A. et al, (2020), BMJ Global Health, 5, e002040 - e002040

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study (vol 396, pg 97, 2020)

Walli-Attaei M. et al, (2020), LANCET, 396, 312 - 312

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study (vol 396, pg 97, 2020)

Walli-Attaei M. et al, (2020), LANCET, 396, 1070 - 1070

Feasibility and implementation of a healthy lifestyles program in a community setting in Ontario, Canada: protocol for a pragmatic mixed methods pilot study

Alvarez E. et al, (2019), BMJ Open, 9, e031298 - e031298

Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study

Rosengren A. et al, (2019), The Lancet Global Health, 7, e748 - e760

Contrasting Patterns of Risk Factors, Treatments and Outcomes in Women and Men in Those With and Without Prior Cardiovascular Disease in High (H), Middle (M), and Low-Income Countries (LIC)

Attaei M. et al, (2019), CIRCULATION, 140, E980 - E980

Financial risk for people living with non-communicable diseases from 18 countries in the PURE study

Murphy A. et al, (2018), European Journal of Public Health, 28

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data.

Attaei MW. et al, (2017), Lancet Public Health, 2, e411 - e419

Load More

Include forthcoming?